Company ProfilePremium

BIOREFERENCE LABORATORIES, INC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
BIOREFERENCE LABORATORIES, INC - Healthcare showcase

Year Founded & Workforce

1981

350,600 Employees

Industry

Healthcare

Services

Diseases & Testing
B

BIOREFERENCE LABORATORIES, INC Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

BIOREFERENCE LABORATORIES, INC Overview

Company Headquarters: New Jersey, US

Founded: 1981

Workforce: ~350,600

Company Working: BioReference Laboratories, Inc. (BioReference) is one of the largest full service clinical diagnostic laboratories in the US. The company offers testing and related services to long term care facilities, employers, physician offices, clinics, hospitals, governmental units, and correctional institutions. It also provides a wide-ranging test that focuses on molecular diagnostics, anatomical pathology, genetics, and women’s health. BioReference is currently present in nine locations of the US (New York, Massachusetts, California, Texas, and others). It is a wholly-owned subsidiary of OPKO Health, Inc.

Strategy

BioReference Laboratories, Inc. focuses on serving multiple markets through several specialized business units with its dedicated sales team and highly trained support personnel. It provides customized healthcare facilities. The company builds its system around the need of the client and practices collaborative medicine. It continuously makes its clinical pipeline to expand the portfolio of therapeutics and diagnostics services.

Company Snapshot

$966M

Revenue

350,600

Employees

1981

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

  • Strong R&D investment
  • Nation’s third largest clinical laboratory

Weaknesses

  • The company has a history of operating loss
  • Intellectual property infringement claims

Opportunities

  • Expansion in the Middle East and Africa
  • Expanding into other medical markets

Threats

  • Obtaining and maintaining with the regulatory approval outside the US

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • BIOREFERENCE LABORATORIES, INC
    • Diseases & Testing

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 966 Mn in 2017 to USD 901.9 Mn in 2019.
BIOREFERENCE LABORATORIES, INC — By Business Segment
Series (USD Mn)201720182019
Sales966990.3901.9
R&D Expenditure126.4125.6117.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.